News
The company said it’s app analyzes weekly urine tests to provide nutrition and lifestyle guidance.
The study will focus on Type 2 diabetes patients.
The company, formerly named Thryve, also hired a new CEO and a chief product officer.
This new infusion of cash brings the company's total funding to $28 million.
The company was founded last year and has raised $2.2 million in seed funding.
The companies said their collaboration will improve access to care, particularly for those who would benefit from additional in-person care.
The new technology is being developed for in-hospital and at-home use.
The funding will help clinicians manage elective recovery backlogs in the NHS.
The study found only 46% of patients eligible for prophylactic low-dose aspirin due to high-risk factors for preeclampsia had gotten a provider recommendation by 16 weeks gestation.
Bush discusses his new company Zus and what tech-first providers need right now.